• New CEO for PacBio, Updated Chemistry for Vega System

    Aug 07 | Diagnostics World | PacBio made several announcements this week: Mark Van Oene is the new President and CEO for the company and new chemistry and software are available for its Vega systems. Both changes aim to position the company for wider platform adoption across labs and research areas. More

  • Biomarkers Bring Long-Awaited Hope to Those at Genetic Risk for ALS

    Aug 05 | Diagnostics World | Blood-based biomarkers predicting when symptoms of amyotrophic lateral sclerosis (ALS) will emerge are expected to catapult the medical research community forward in the quest to prevent the fatal neurodegenerative disorder. Researchers from the University of Miami Miller School of Medicine have been spearheading the Pre-Symptomatic Familial ALS (Pre-fALS) study collecting longitudinal data and biological samples from people at elevated genetic risk for ALS since the project’s 2007 inception. More

  • Samsung, UCSF Study Smartwatch Data as Potential Biomarkers of Cognitive Health

    Aug 04 | Diagnostics World | Smartwatches could one day do more than track steps, sleep, and heart rate. Researchers at the University of California San Francisco (UCSF) are working with Samsung to determine whether physiological data collected passively by a smartwatch can help identify early changes in cognitive function. More

  • Follow the Money: Novel NeuroAI Model, Autoimmune, Inflammatory Disease Treatment, Drug Discovery

    Jul 29 | Diagnostics World | Fresenius expands its access to innovation networks through its own corporate venture capital fund over the next five years; Transcripta Bio's closed-loop discovery engine is designed to use transcriptomic signature matching to identify drugs whose molecular signatures are the inverse of patient-derived disease signatures; and more. More

  • Seegene Multiplex PCR Test, QIAGEN Launches New Panel, At-Home HIV Tests

    Jul 28 | Diagnostics World | Myriad Genetics announces the full commercial launch of FirstGene Multiple Prenatal Screen; Amprion reaches an agreement with Decathlon Capital Partners for a significant growth-funding investment; and more. More

  • Approaching Diagnostic Development with Scalability, Regulatory Readiness, and Long-Term Success in Mind

    Jul 24 | Diagnostics World | Growing momentum in biomarker discovery, advancing analytical technologies, and a shift toward personalized medicine have created unprecedented possibilities for diagnostic development. The pace at which this progress translates to novel, widely adopted, clinically validated diagnostic tools remains slow, but not for lack of innovation. More

  • Vibrating Pill Could Both Treat Eating Disorders and Predict Relapse

    Jul 22 | Diagnostics World | Digestive sensations profoundly affect mental health through the bidirectional gut-brain axis, and in the case of anorexia nervosa (AN) tends to do so at crisis proportions. The disorder has one of the highest mortality rates of any psychiatric disorder with suicide being the leading cause of death. More

  • Nanotechnology for Point-of-Care Screening of Gut Health

    Jul 21 | Diagnostics World | Indole-3-propionic acid (IPA) is increasingly recognized as a critical chemical shield and promising biomarker for gut inflammation. Levels of IPA are starkly deficient in the blood of patients with active ulcerative colitis (UC), but the gold standard measurement technique of liquid chromatography-mass spectrometry (LC-MS) is costly and requires highly trained technicians to run the equipment, limiting its use to specialized research cohorts and clinical trials. More

  • Epi One Aims to ‘Democratize’ Early Detection One Cancer at a Time

    Jul 16 | Diagnostics World | Much like the trajectory of infectious disease diagnostics was changed by PCR and molecular methods, Epi One is looking to alter the course of cancer diagnostics with direct, highly sensitive molecular detection of specific epigenetic biomarkers of multiple malignancies. First out of the gate will be a prostate cancer re-biopsy decision tissue-based assay, immediately followed by an initial prostate cancer biopsy blood-based test. More

  • New Alzheimer’s Blood Test Flags Symptom Onset

    Jul 14 | Diagnostics World | Researchers from Washington University School of Medicine, St. Louis have showed that elevated levels of a set of circular RNAs (circRNAs) in the blood nearly tripled patients’ risk of developing Alzheimer’s Disease (AD) symptoms, suggesting these molecules are more sensitive to symptom onset than traditional AD biomarkers. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more